Filing Details
- Accession Number:
- 0001209191-14-075973
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-16 18:22:21
- Reporting Period:
- 2014-12-15
- Filing Date:
- 2014-12-16
- Accepted Time:
- 2014-12-16 18:22:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1103021 | Biodelivery Sciences International Inc | BDSI | Pharmaceutical Preparations (2834) | 352089858 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1301715 | A Mark Sirgo | C/O Biodelivery Sciences Intl, Inc., 801 Corporate Center Drive, Suite 210 Raleigh NC 27607 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-12-15 | 2,500 | $12.23 | 923,602 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- On December 15, 2014, the Reporting Person purchased an aggregate of 2,500 shares of the Issuer's Common Stock at a weighted average price of $12.23. The highest sale price for the Common Stock was $12.25 per share and the lowest sale price was $12.21 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.